NCT05858047View on ClinicalTrials.gov

An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

February 21, 2024

Study Completion Date

February 21, 2024

Conditions
Effects, Drug Side
Interventions
DRUG

Placebo

Administered orally, once daily (QD)

DRUG

SYHX1901

Administered orally, once daily (QD)

Trial Locations (1)

Unknown

Huashan Hospital Affiliated to Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

CSPC Ouyi Pharmaceutical Co., Ltd.

INDUSTRY

NCT05858047 - An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter